Sonoma Pharmaceuticals, Inc. (SNOA) Earnings
|
Expand Research on SNOA
| Next EPS Date | N/A | EPS Growth Rate | +23.8% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -482.8% | Revenue Growth Rate | +19.4% *Last Qtr. |
| Average % Move 1-Wk after EPS | +3.9% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/10/26  |
Q326 | -$0.48 | -$0.05 | -$0.43 | $4.3M | $5.24M | N/A |  | | Details | |
| 11/4/25 |
Q226 | -$0.32 | $0.00 | -$0.32 | $5.6M | N/A | N/A | | | Details | |
| 2/6/25 | Q325 | -$0.63 | -$0.69 | +$0.06 | $3.6M | $4M | N/A | | | Details | |
| 11/8/24 |
Q225 | -$0.59 | -$0.05 | -$0.54 | $3.6M | $3.9M | N/A | | | Details | |
| 8/12/24 | Q125 | N/A | -$0.06 | N/A | N/A | $3.94M | N/A | N/A | N/A | ||
| 8/8/24 | Q424 | N/A | -$0.06 | N/A | N/A | $3.94M | N/A | N/A | N/A | ||
| 2/13/24 | Q324 | N/A | -$0.21 | N/A | $3.14M | $3.76M | N/A | N/A | N/A | ||
| 11/13/23 | Q224 | N/A | -$0.19 | N/A | $2.73M | $3.59M | N/A | N/A | N/A |
